FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2892054361> ?p ?o ?g. }

• W2892054361 endingPage "41" @default.
• W2892054361 startingPage "31" @default.
• W2892054361 abstract "Previous studies have demonstrated that the selective cyclooxygenase‐2 (COX‐2) inhibitor celecoxib shows efficacy against multiple cancers, including hepatocellular carcinoma. However, whether celecoxib is effective in alleviating steatosis during hepatocarcinogenesis is unknown. In a rapid hepatocellular carcinoma (HCC) mouse model established via hydrodynamic transfection of activated forms of AKT and c‐Met proto‐oncogenes, we investigated the antisteatotic and anticarcinogenic efficacy of celecoxib in vivo. Multiple HCC cell lines were employed for in vitro evaluation. Additionally, immunoblotting, immunohistochemistry, hematoxylin and eosin staining and Oil Red O staining were applied for mechanistic investigation. The results revealed that if celecoxib was administered in the early stage of AKT/c‐Met‐induced HCC, it resulted in disease stabilization. Moreover, celecoxib could alleviate lipid accumulation in the HCC mice and in an oleic acid‐induced in vitro hepatic steatosis model. Further evidence at the molecular level indicated that celecoxib down‐regulated the expression of phospho‐ERK (Thr202/Tyr204) and proliferating cell nuclear antigen (PCNA) in the HCC mice. In addition, celecoxib efficiently repressed the phosphor‐Akt (Thr308)/fatty acid synthase (FASN) axis both in vivo and in vitro. Altogether, this study suggests that celecoxib exerts its antilipogenic efficacy by targeting a COX‐2/AKT/FASN cascade, which contributes to its ability to delay hepatocarcinogenesis." @default.
• W2892054361 created "2018-09-27" @default.
• W2892054361 creator A5001484266 @default.
• W2892054361 creator A5008514175 @default.
• W2892054361 creator A5011487190 @default.
• W2892054361 creator A5022526821 @default.
• W2892054361 creator A5025876382 @default.
• W2892054361 creator A5026143070 @default.
• W2892054361 creator A5052102629 @default.
• W2892054361 creator A5052974806 @default.
• W2892054361 creator A5074734978 @default.
• W2892054361 creator A5080566282 @default.
• W2892054361 date "2018-09-20" @default.
• W2892054361 modified "2023-10-18" @default.
• W2892054361 title "Celecoxib alleviates AKT/c‐Met‐triggered rapid hepatocarcinogenesis by suppressing a novel COX‐2/AKT/FASN cascade" @default.
• W2892054361 cites W1648593433 @default.
• W2892054361 cites W1900754193 @default.
• W2892054361 cites W1965037168 @default.
• W2892054361 cites W1967482096 @default.
• W2892054361 cites W1987797584 @default.
• W2892054361 cites W1988508668 @default.
• W2892054361 cites W1988924112 @default.
• W2892054361 cites W1992142919 @default.
• W2892054361 cites W1996785337 @default.
• W2892054361 cites W2017394099 @default.
• W2892054361 cites W2018992554 @default.
• W2892054361 cites W2019916027 @default.
• W2892054361 cites W2020430786 @default.
• W2892054361 cites W2024233889 @default.
• W2892054361 cites W2037952228 @default.
• W2892054361 cites W2041196096 @default.
• W2892054361 cites W2042207719 @default.
• W2892054361 cites W2045084840 @default.
• W2892054361 cites W2048548143 @default.
• W2892054361 cites W2051686420 @default.
• W2892054361 cites W2053978445 @default.
• W2892054361 cites W2055729918 @default.
• W2892054361 cites W2060267362 @default.
• W2892054361 cites W2061743943 @default.
• W2892054361 cites W2070895117 @default.
• W2892054361 cites W2074648434 @default.
• W2892054361 cites W2088905899 @default.
• W2892054361 cites W2093265805 @default.
• W2892054361 cites W2097997344 @default.
• W2892054361 cites W2111868355 @default.
• W2892054361 cites W2126723608 @default.
• W2892054361 cites W2136710786 @default.
• W2892054361 cites W2142114461 @default.
• W2892054361 cites W2145595073 @default.
• W2892054361 cites W2151807579 @default.
• W2892054361 cites W2153178365 @default.
• W2892054361 cites W2163335322 @default.
• W2892054361 cites W2169385554 @default.
• W2892054361 cites W2294090452 @default.
• W2892054361 cites W2530811934 @default.
• W2892054361 cites W2737501041 @default.
• W2892054361 doi "https://doi.org/10.1002/mc.22904" @default.
• W2892054361 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30182439" @default.
• W2892054361 hasPublicationYear "2018" @default.
• W2892054361 type Work @default.
• W2892054361 sameAs 2892054361 @default.
• W2892054361 citedByCount "18" @default.
• W2892054361 countsByYear W28920543612019 @default.
• W2892054361 countsByYear W28920543612020 @default.
• W2892054361 countsByYear W28920543612021 @default.
• W2892054361 countsByYear W28920543612022 @default.
• W2892054361 countsByYear W28920543612023 @default.
• W2892054361 crossrefType "journal-article" @default.
• W2892054361 hasAuthorship W2892054361A5001484266 @default.
• W2892054361 hasAuthorship W2892054361A5008514175 @default.
• W2892054361 hasAuthorship W2892054361A5011487190 @default.
• W2892054361 hasAuthorship W2892054361A5022526821 @default.
• W2892054361 hasAuthorship W2892054361A5025876382 @default.
• W2892054361 hasAuthorship W2892054361A5026143070 @default.
• W2892054361 hasAuthorship W2892054361A5052102629 @default.
• W2892054361 hasAuthorship W2892054361A5052974806 @default.
• W2892054361 hasAuthorship W2892054361A5074734978 @default.
• W2892054361 hasAuthorship W2892054361A5080566282 @default.
• W2892054361 hasBestOaLocation W28920543611 @default.
• W2892054361 hasConcept C134018914 @default.
• W2892054361 hasConcept C150903083 @default.
• W2892054361 hasConcept C190283241 @default.
• W2892054361 hasConcept C207001950 @default.
• W2892054361 hasConcept C2776175330 @default.
• W2892054361 hasConcept C2776467144 @default.
• W2892054361 hasConcept C502942594 @default.
• W2892054361 hasConcept C55493867 @default.
• W2892054361 hasConcept C75217442 @default.
• W2892054361 hasConcept C86554907 @default.
• W2892054361 hasConcept C86803240 @default.
• W2892054361 hasConcept C98274493 @default.
• W2892054361 hasConceptScore W2892054361C134018914 @default.
• W2892054361 hasConceptScore W2892054361C150903083 @default.
• W2892054361 hasConceptScore W2892054361C190283241 @default.
• W2892054361 hasConceptScore W2892054361C207001950 @default.
• W2892054361 hasConceptScore W2892054361C2776175330 @default.
• W2892054361 hasConceptScore W2892054361C2776467144 @default.
• W2892054361 hasConceptScore W2892054361C502942594 @default.

• next